OpenURL Connection Search

Select item for more details and to access through your institution.

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.
Published in:
European Heart Journal, 2019, v. 40, n. 22, p. 1778, doi. 10.1093/eurheartj/ehz119
By:
- Kojima, Sunao;
- Matsui, Kunihiko;
- Hiramitsu, Shinya;
- Hisatome, Ichiro;
- Waki, Masako;
- Uchiyama, Kazuaki;
- Yokota, Naoto;
- Tokutake, Eiichi;
- Wakasa, Yutaka;
- Jinnouchi, Hideaki;
- Kakuda, Hirokazu;
- Hayashi, Takahiro;
- Kawai, Naoki;
- Mori, Hisao;
- Sugawara, Masahiro;
- Ohya, Yusuke;
- Kimura, Kazuo;
- Saito, Yoshihiko;
- Ogawa, Hisao
Publication type:
Article
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Published in:
Hypertension Research, 2023, v. 46, n. 6, p. 1417, doi. 10.1038/s41440-023-01198-x
By:
- Kohagura, Kentaro;
- Kojima, Sunao;
- Uchiyama, Kazuaki;
- Yokota, Naoto;
- Tokutake, Eiichi;
- Wakasa, Yutaka;
- Hiramitsu, Shinya;
- Waki, Masako;
- Jinnouchi, Hideaki;
- Kakuda, Hirokazu;
- Hayashi, Takahiro;
- Kawai, Naoki;
- Sugawara, Masahiro;
- Mori, Hisao;
- Tsujita, Kenichi;
- Matsui, Kunihiko;
- Hisatome, Ichiro;
- Ohya, Yusuke;
- Kimura, Kazuo;
- Saito, Yoshihiko
Publication type:
Article
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
Published in:
Rheumatology, 2022, v. 61, n. 6, p. 2346, doi. 10.1093/rheumatology/keab739
By:
- Kojima, Sunao;
- Uchiyama, Kazuaki;
- Yokota, Naoto;
- Tokutake, Eiichi;
- Wakasa, Yutaka;
- Hiramitsu, Shinya;
- Waki, Masako;
- Jinnouchi, Hideaki;
- Kakuda, Hirokazu;
- Hayashi, Takahiro;
- Kawai, Naoki;
- Sugawara, Masahiro;
- Mori, Hisao;
- Tsujita, Kenichi;
- Matsui, Kunihiko;
- Hisatome, Ichiro;
- Ohya, Yusuke;
- Kimura, Kazuo;
- Saito, Yoshihiko;
- Ogawa, Hisao
Publication type:
Article
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1358, doi. 10.1002/cpt.3217
By:
- Sugawara, Masahiro;
- Kojima, Sunao;
- Hisatome, Ichiro;
- Matsui, Kunihiko;
- Uchiyama, Kazuaki;
- Yokota, Naoto;
- Tokutake, Eiichi;
- Wakasa, Yutaka;
- Hiramitsu, Shinya;
- Waki, Masako;
- Jinnouchi, Hideaki;
- Kakuda, Hirokazu;
- Hayashi, Takahiro;
- Kawai, Naoki;
- Mori, Hisao;
- Tsujita, Kenichi;
- Ohya, Yusuke;
- Kimura, Kazuo;
- Saito, Yoshihiko;
- Ogawa, Hisao
Publication type:
Article
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
Published in:
Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 965, doi. 10.1007/s10557-022-07347-7
By:
- Kojima, Sunao;
- Uchiyama, Kazuaki;
- Yokota, Naoto;
- Tokutake, Eiichi;
- Wakasa, Yutaka;
- Hiramitsu, Shinya;
- Waki, Masako;
- Jinnouchi, Hideaki;
- Kakuda, Hirokazu;
- Hayashi, Takahiro;
- Kawai, Naoki;
- Sugawara, Masahiro;
- Mori, Hisao;
- Tsujita, Kenichi;
- Matsui, Kunihiko;
- Hisatome, Ichiro;
- Ohya, Yusuke;
- Kimura, Kazuo;
- Saito, Yoshihiko;
- Ogawa, Hisao
Publication type:
Article
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)
Published in:
Diabetes Therapy, 2024, v. 15, n. 6, p. 1403, doi. 10.1007/s13300-024-01575-w
By:
- Fukuda, Masahiro;
- Sakuma, Ichiro;
- Wakasa, Yutaka;
- Funayama, Hideaki;
- Kondo, Akira;
- Itabashi, Naoki;
- Maruyama, Yasuyuki;
- Kamiyama, Takashi;
- Utsunomiya, Yasunori;
- Yamauchi, Akira;
- Yoshii, Hidenori;
- Yamada, Hirokazu;
- Mochizuki, Koichi;
- Sugawara, Masahiro
Publication type:
Article
Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).
Published in:
Diabetes Therapy, 2023, v. 14, n. 10, p. 1639, doi. 10.1007/s13300-023-01442-0
By:
- Ishii, Hitoshi;
- Kamei, Nozomu;
- Shimono, Dai;
- Niiya, Tetsuji;
- Tosaki, Takahiro;
- Kitazawa, Toru;
- Suzuki, Daisuke;
- Wakasa, Yutaka;
- Seino, Hiroaki;
- Oishi, Mariko;
- Ohashi, Hiroshi;
- Higami, Kenshi;
- Akai, Hiroaki
Publication type:
Article
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).
Published in:
Diabetes Therapy, 2023, v. 14, n. 9, p. 1517, doi. 10.1007/s13300-023-01438-w
By:
- Sugawara, Masahiro;
- Fukuda, Masahiro;
- Sakuma, Ichiro;
- Wakasa, Yutaka;
- Funayama, Hideaki;
- Kondo, Akira;
- Itabashi, Naoki;
- Maruyama, Yasuyuki;
- Kamiyama, Takashi;
- Utsunomiya, Yasunori;
- Yamauchi, Akira;
- Yoshii, Hidenori;
- Yamada, Hirokazu;
- Mochizuki, Koichi;
- Seino, Hiroaki;
- Murata, Kaori;
- Yatagai, Shigeo;
- Koyama, Hiroshi;
- Yamamoto, Hareaki;
- Shimizu, Miho
Publication type:
Article

Found: 8